Feedback / Questions
Lovaxin B (diznalimgene lisbac) - OS Therapies
https://www.newsfilecorp.com/release/277410/OS-Therapies-Announces-Successful-preMarketing-Authorisation-Application-Meeting-with-UK-MHRA-Regarding-the-Phase-2b-Clinical-Trial-of-OSTHER2-in-the-Prevention-or-Delay-of-Recurrent-Fully-Resected-Pulmonary-Metastatic-Osteosarcoma
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next